Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Montelukast + Loratadine for Pediatric Asthma
NCT03372473Phase 3Completed
- Sponsor
- Innovación y Desarrollo de Estrategias en Salud
- Start
- Jan 2016
- Primary completion
- Feb 2016
- Modality
- Orthosteric Ligands
01
Overview
A Phase 3 trial of loratadine in asthma, sponsored by Innovación y Desarrollo de Estrategias en Salud. Started Jan 2016; status: completed.
02
Drugs
loratadine
03
Conditions
asthma
Beyond the preview
Go deeper on NCT03372473.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03372473.